Healthcare Contract Research Outsourcing Market
Healthcare Contract Research Outsourcing Market Analysis by Service (Clinical Trial Services, Regulatory Services, Clinical Data, Management & Biometrics, Medical Writing), by Therapeutic Area (Oncology/Hematology, CNS, Infectious Diseases), by End User & Regional Forecast 2021 to 2028
Analysis of Healthcare Contract Research Outsourcing market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Healthcare Contract Research Outsourcing Market Outlook (2021 to 2028)
The global healthcare contract research outsourcing market is anticipated to rise at a CAGR of 6.6% from 2021 to 2028. In 2020, revenue from healthcare contract research outsourcing was US$ 38.4 Bn, which is expected to reach US$ 63.09 Bn by the end of 2028.
| Report Attributes | Details |
|---|---|
| Healthcare Contract Research Outsourcing Market Size (2020) | US$ 38.4 Bn |
| Projected Year Value (2028) | US$ 63.09 Bn |
| Global Market Growth Rate (2021 to 2028) | 6.6% CAGR |
| North America Market Share (2028) | 43.1% |
| Key Companies Profiled | Syneos Health; PAREXEL International; ICON plc; Charles River; IQVIA; Medpace; Pharmaceutical Product Development, LLC. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Healthcare Contract Research Outsourcing from 2017 to 2020 Vs Market Outlook for 2021 to 2028
“Rising Privatization of Clinical Trials Driving Demand for Healthcare Contract Research Outsourcing Services”
As per Fact.MR, a market research and competitive intelligence provider, the global market for healthcare contract research outsourcing (CRO) was valued at US$ 40.34 Bn in 2021.
Demand for contract research outsourcing in the healthcare sector is expected to rise due to increasing pressure on drug developers related to clinical data management, regulatory affairs outsourcing, and demanding safety standards.
Not only drug production, but also clinical trials, are outsourced by healthcare and pharmaceutical corporations. Preclinical outsourcing to developed countries is becoming more common as clinical trials become increasingly privatized.
Rising complexity of regulatory procedures and increased involvement of healthcare providers in drug approval and reimbursement are likely to drive the worldwide healthcare contract research outsourcing market.
The competence of CROs in therapeutic areas, as well as regional filing methods, helps the market growth. A regulatory filing assistance is provided by a variety of contract research groups at various phases of medication development.
All of these factors are expected to drive the market at 6.6% CAGR from 2021 to 2028.
Which Key Trend is Driving Demand for Healthcare Contract Research Outsourcing?
“Development of Precision Medicines to Augment Market Growth”
Precision medicine is a relatively new idea in healthcare that is gaining traction due to a shift in medicine's focus from reaction to prevention. Precision medicine is becoming more crucial for focused therapy due to the high expenses of trial-and-error medicine.
Majority of CROs are focusing on precision medicine in order to reduce the overall costs of drug development failure and the time it takes. CROs give support and direction for precision medicine trials at every level.
Because developing a comprehensive infrastructure with the most up-to-date facilities is costly, many small businesses are outsourcing R&D to preclinical CRO services to save large costs and save time and resources required to finish the procedure, which includes everything from drug conception through FDA marketing approval.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Challenging Factors for Market Expansion?
“Lack of Skilled Professionals & Variation in Regulatory Guidelines Hampering Market Growth”
Lack of awareness in the field of healthcare CRO and differences in regulatory rules and licensing processes in many countries are hampering the market growth.
Implementation of sophisticated technology is hampered by a lack of skilled employees. Although research outsourcing can save money, it can also risk quality and efficacy. Because the outsourced research job involves clinical trials outsourcing, medical affairs outsourcing, medical writing outsourcing, and regulatory affairs outsourcing, it is critical to ensure that the product is of sufficient quality.
Outsourced research operations are still not being handled at the required standards, and some parts of the sector are wary of outsourcing.
Which Region is Expected to Lead the Global Healthcare Contract Research Outsourcing Market?
“Rise in Government Support for R&D Activities to Propel Industry Growth in North America”
North America is expected to account for is expected to account 43.10% share of the healthcare contract research outsourcing market by 2028 due to the large demand for preclinical CRO services and solutions. The region is also a hub of advanced healthcare infrastructure.
Increasing government support for R&D activities through grants and funds to research institutes and corporations is driving the market growth in North America.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Insights
Why is the U.S. an Emerging Market for Healthcare Contract Research Outsourcing Service Providers?
“Prominent Presence of Well-established Enterprises Boosting Market Revenue”
The United States dominates the healthcare contract research outsourcing business due to the high-quality standards of the pharmaceutical industry. The market revenue growth is also aided by the existence of well-established enterprises and easy access to specialized technologies.
Additionally, the rapid growth of its biosimilar and biologics markets, as well as an increase in clinical trial activities, will propel the healthcare contract research outsourcing industry forward.
What is the Healthcare Contract Research Outsourcing Market Outlook for China?
“High Prevalence of Chronic Diseases to Drive Market Expansion”
The market in China is expected to rise at a high rate due to the high prevalence of chronic diseases, the availability of diverse populations, the ease with which patients can be recruited and retained, and the implementation of laws that adhere to established norms.
The market is expected to increase over the coming years due to expenditures on facilities and resources in functional services such as central laboratories, imaging, and clinical supplies.
Category-wise Insights
Why are Clinical Trial Services Gaining Immense Traction?
“Clinical Trial Services Remain Preferred to Evaluate Efficacy of New Medicines”
The clinical trial services segment is expected to dominate the global market over the forecast period. Outsourcing clinical trial services to CROs is expected to add to the segment's big market share in the near future by lowering R&D costs and shortening drug development timelines.
Emergence of novel treatments and advanced technologies, rapid deployment of advanced technologies, and rising need for new medicines evaluation are driving the demand for clinical trial services.
Technological advancements in clinical trial services and rising demand for contract research organizations to conduct clinical trials will drive market growth over the coming years.
Which End User Will Emerge as Key Market Contributor?
“Pharmaceutical Companies Maintaining Lead Owing to Cost-effective Advantages”
Pharmaceutical companies are concentrating on producing technology that is both more efficient and safe. Increasing investments in research and development are projected to help the pharmaceutical companies segment grow their revenue during the forecast period. Pharmaceutical businesses are rapidly outsourcing R&D to CROs in order to save money on in-house research infrastructure.
Due to increased demand for creative products and patent expiration, small pharmaceutical companies are also looking for breakthroughs in product development through CRO solutions.
Rising complexity of drug development, the need for shorter drug development timelines, cost-effectiveness, and the benefit of gaining therapeutic expertise associated with outsourcing services have favored outsourcing services to CROs, resulting in a significant share of pharmaceutical companies in the global healthcare contract research outsourcing market.
Competitive Landscape
Key companies outsource complicated R&D tasks that must be monitored regularly. Healthcare CROs function and manage the procedures of bringing new goods to market according to timelines set by customers.
Healthcare contract research outsourcing service providers are now developing alliances to broaden their market reach by providing services and solutions over a broad market sector and enhancing client-contractor relationships.
For instance,
- In March 2020, Medpace Holdings, Inc., a healthcare CRO, teamed up with Medidata Solutions, a software-as-a-service firm, to combine its imaging methods and workflow with Medidata Rave imaging for clinical trials.
Key Segments Covered in Healthcare Contract Research Outsourcing Industry Research
-
By Service:
- Clinical Trial Services
- Preclinical
- Clinical
- Regulatory Services
- Clinical Data Management & Biometrics
- Electronic Data Capture
- Electronic Patient Recorded Outcomes
- Others
- Medical Writing
- Pharmacovigilance
- Site Management Protocol
- Others
- Clinical Trial Services
-
By Therapeutic Area:
- Oncology/Hematology
- CNS
- CV/Metabolic
- Respiratory
- Infectious Diseases
- Immunology
- Rare Diseases
- Medical Devices
- Others
-
By End User:
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Academic Institutes & Government Organizations
-
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2020 and Forecast, 2021 to 2028
- 6. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2028, By Service
- 6.1. Clinical Trial Services
- 6.2. Regulatory Services
- 6.3. Clinical Data Management & Biometrics
- 6.4. Medical Writing
- 6.5. Pharmacovigilance
- 6.6. Site Management Protocol
- 6.7. Others
- 7. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2028, by Therapeutic Area
- 7.1. Oncology/Hematology
- 7.2. CNS
- 7.3. CV/Metabolic
- 7.4. Respiratory
- 7.5. Infectious Diseases
- 7.6. Immunology
- 7.7. Rare Diseases
- 7.8. Medical Devices
- 7.9. Others
- 8. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2028, by End User
- 8.1. Pharmaceutical Companies
- 8.2. Biotechnology Companies
- 8.3. Medical Device Companies
- 8.4. Academic Institutes & Government Organizations
- 9. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2028, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 11. Latin America Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 12. Europe Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 13. East Asia Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 14. South Asia & Oceania Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 15. Middle East and Africa Market Analysis 2017 to 2020 and Forecast 2021 to 2028
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Syneos Health
- 17.2. PAREXEL International
- 17.3. ICON plc
- 17.4. Charles River
- 17.5. IQVIA
- 17.6. Medpace
- 17.7. Pharmaceutical Product Development, LLC.
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 2: Global Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 4: Global Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 5: Global Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2020
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2021 to 2028
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2021 to 2028
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 16: North America Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 17: North America Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 19: North America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 20: North America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 28: Latin America Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 29: Latin America Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 31: Latin America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 32: Latin America Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 40: Europe Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 41: Europe Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 43: Europe Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 44: Europe Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 52: East Asia Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 53: East Asia Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 55: East Asia Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 56: East Asia Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2020
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2021 to 2028
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2028
Table 76: MEA Market Value (US$ Mn) Analysis, by Service, 2017 to 2020
Table 77: MEA Market Value (US$ Mn) Analysis, by Service, 2021 to 2028
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Service, 2021 to 2028
Table 79: MEA Market Value (US$ Mn) Analysis, by Therapeutic Area, 2017 to 2020
Table 80: MEA Market Value (US$ Mn) Analysis, by Therapeutic Area, 2021 to 2028
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Therapeutic Area, 2021 to 2028
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2020
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2021 to 2028
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2028
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 4: Global Market Incremental $ Opportunity, 2021 to 2028
Figure 5: Global Market Share and BPS Analysis by Service, 2021 & 2028
Figure 6: Global Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 7: Global Market Attractiveness Analysis by Service, 2021 to 2028
Figure 8: Global Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 9: Global Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 10: Global Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 11: Global Market Share and BPS Analysis by End User, 2021 & 2028
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 13: Global Market Attractiveness Analysis by End User, 2021 to 2028
Figure 14: Global Market Share and BPS Analysis by Region, 2021 & 2028
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2021 to 2028
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2028
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 20: North America Market Incremental $ Opportunity, 2021 to 2028
Figure 21: North America Market Share Analysis by Country, 2021 & 2028
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 23: North America Market Attractiveness Analysis by Country, 2021 to 2028
Figure 24: North America Market Share and BPS Analysis by Service, 2021 & 2028
Figure 25: North America Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 26: North America Market Attractiveness Analysis by Service, 2021 to 2028
Figure 27: North America Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 28: North America Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 29: North America Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 30: North America Market Share and BPS Analysis by End User, 2021 & 2028
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 32: North America Market Attractiveness Analysis by End User, 2021 to 2028
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 36: Latin America Market Incremental $ Opportunity, 2021 to 2028
Figure 37: Latin America Market Share Analysis by Country, 2021 & 2028
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 39: Latin America Market Attractiveness Analysis by Country, 2021 to 2028
Figure 40: Latin America Market Share and BPS Analysis by Service, 2021 & 2028
Figure 41: Latin America Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 42: Latin America Market Attractiveness Analysis by Service, 2021 to 2028
Figure 43: Latin America Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 44: Latin America Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 45: Latin America Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 46: Latin America Market Share and BPS Analysis by End User, 2021 & 2028
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 48: Latin America Market Attractiveness Analysis by End User, 2021 to 2028
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 52: Europe Market Incremental $ Opportunity, 2021 to 2028
Figure 53: Europe Market Share Analysis by Country, 2021 & 2028
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 55: Europe Market Attractiveness Analysis by Country, 2021 to 2028
Figure 56: Europe Market Share and BPS Analysis by Service, 2021 & 2028
Figure 57: Europe Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 58: Europe Market Attractiveness Analysis by Service, 2021 to 2028
Figure 59: Europe Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 60: Europe Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 61: Europe Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 62: Europe Market Share and BPS Analysis by End User, 2021 & 2028
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 64: Europe Market Attractiveness Analysis by End User, 2021 to 2028
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 68: East Asia Market Incremental $ Opportunity, 2021 to 2028
Figure 69: East Asia Market Share Analysis by Country, 2021 & 2028
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 71: East Asia Market Attractiveness Analysis by Country, 2021 to 2028
Figure 72: East Asia Market Share and BPS Analysis by Service, 2021 & 2028
Figure 73: East Asia Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 74: East Asia Market Attractiveness Analysis by Service, 2021 to 2028
Figure 75: East Asia Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 76: East Asia Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 77: East Asia Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 78: East Asia Market Share and BPS Analysis by End User, 2021 & 2028
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 80: East Asia Market Attractiveness Analysis by End User, 2021 to 2028
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2021 to 2028
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2021 & 2028
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2021 to 2028
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Service, 2021 & 2028
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Service, 2021 to 2028
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2021 & 2028
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2021 to 2028
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2020
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2021 to 2028
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2028
Figure 100: MEA Market Incremental $ Opportunity, 2021 to 2028
Figure 101: MEA Market Share Analysis by Country, 2021 & 2028
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2021 to 2028
Figure 103: MEA Market Attractiveness Analysis by Country, 2021 to 2028
Figure 104: MEA Market Share and BPS Analysis by Service, 2021 & 2028
Figure 105: MEA Market Y-o-Y Growth Projections by Service, 2021 to 2028
Figure 106: MEA Market Attractiveness Analysis by Service, 2021 to 2028
Figure 107: MEA Market Share and BPS Analysis by Therapeutic Area, 2021 & 2028
Figure 108: MEA Market Y-o-Y Growth Projections by Therapeutic Area, 2021 to 2028
Figure 109: MEA Market Attractiveness Analysis by Therapeutic Area, 2021 to 2028
Figure 110: MEA Market Share and BPS Analysis by End User, 2021 & 2028
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2021 to 2028
Figure 112: MEA Market Attractiveness Analysis by End User, 2021 to 2028
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the total market worth of healthcare contract research outsourcing in 2020?
The global healthcare contract research outsourcing market totaled a valuation of US$ 38.4 Bn in 2020.
What is the anticipated CAGR of the healthcare contract research outsourcing market over the forecast period?
The global market for healthcare contract research outsourcing is estimated to expand at a CAGR of 6.6% from 2021 to 2028.
Who are the key providers of healthcare contract research outsourcing services?
Syneos Health, PAREXEL International, ICON plc, Charles River, and IQVIA are key providers of healthcare contract research outsourcing solutions.
Which are the top 5 countries driving demand for healthcare CRO services?
The U.S., U.K, Germany, Japan, and China are expected to drive most demand for healthcare CRO services.
Which is the leading region in the global healthcare contract research outsourcing market?
North America accounts for 43.1% share of the global healthcare contract research outsourcing market.
Which growth trends are driving the market for healthcare contract research outsourcing solutions and services?
Increasing prevalence of chronic diseases and rising research & development of novel drug products are driving market growth.
Healthcare Contract Research Outsourcing Market